262 related articles for article (PubMed ID: 37876534)
21. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
22. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
Gong X; Ren F
Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568
[TBL] [Abstract][Full Text] [Related]
23. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Li Y; Liu H
Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446
[TBL] [Abstract][Full Text] [Related]
24. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
25. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
26. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database.
Lin P; Hu XL; Hu YY; Liu MY; Wang QY; Ding Y; Ye JC
Ann Transl Med; 2022 Sep; 10(17):923. PubMed ID: 36172089
[TBL] [Abstract][Full Text] [Related]
28. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory Effect of Fingolimod on Head and Neck Squamous Cell Carcinoma and Its Mechanism: Gene Set Enrichment Analysis.
Chang L; Xie C; Chou K; Meng Q; Zhao L
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):150-157. PubMed ID: 37715396
[TBL] [Abstract][Full Text] [Related]
30. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.
Shen Y; Wei Z; Zhou C; Song J; Wang J; Wang J; Wu L; Fang S; Shen Z
J Clin Lab Anal; 2022 Sep; 36(9):e24600. PubMed ID: 35870182
[TBL] [Abstract][Full Text] [Related]
31. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
Front Genet; 2022; 13():947551. PubMed ID: 35938003
[No Abstract] [Full Text] [Related]
32. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
[TBL] [Abstract][Full Text] [Related]
33. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
34. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
35. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Zhong Q; Zhou L; Zhu D
J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma.
Guo Z; Zhao Y; Xu M; Zhao L; Wang X
J Gene Med; 2024 Feb; 26(2):e3671. PubMed ID: 38384136
[TBL] [Abstract][Full Text] [Related]
38. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
[TBL] [Abstract][Full Text] [Related]
39. MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma.
Zhao C; Wei C; Chen X; Li P
Biomed Res Int; 2022; 2022():7281120. PubMed ID: 35924262
[TBL] [Abstract][Full Text] [Related]
40. Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease.
Wang Y; Shen Z; Wu H; Yu Z; Wu X; Zhou L; Guo F
Brain Res; 2023 Nov; 1819():148545. PubMed ID: 37619853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]